Tatapudi V - Search Results

1

A Propensity-Matched Cohort Study of Tocilizumab in Patients With Coronavirus Disease 2019.

Lewis TC, Adhikari S, Tatapudi V, Holub M, Kunichoff D, Troxel AB, Montgomery RA, Sterman DH. Lewis TC, et al. Among authors: tatapudi v. Crit Care Explor. 2020 Nov 16;2(11):e0283. doi: 10.1097/CCE.0000000000000283. eCollection 2020 Nov. Crit Care Explor. 2020. PMID: 33225307 Free PMC article.

2

Pharmacologic Complement Inhibition in Clinical Transplantation.

Tatapudi VS, Montgomery RA. Tatapudi VS, et al. Curr Transplant Rep. 2017;4(2):91-100. doi: 10.1007/s40472-017-0148-7. Epub 2017 Apr 20. Curr Transplant Rep. 2017. PMID: 29214126 Free PMC article. Review.

3

IgG Degrading Enzyme of Streptococcus Pyogenes: An Exciting New Development in Desensitization Therapy.

Montgomery RA, Lonze BE, Tatapudi VS. Montgomery RA, et al. Transplantation. 2018 Jan;102(1):2-4. doi: 10.1097/TP.0000000000002003. Transplantation. 2018. PMID: 29271867 No abstract available.

4

Early Conversion from Tacrolimus to Belatacept in a Highly Sensitized Renal Allograft Recipient with Calcineurin Inhibitor-Induced de novo Post-Transplant Hemolytic Uremic Syndrome.

Tatapudi VS, Lonze BE, Wu M, Montgomery RA. Tatapudi VS, et al. Case Rep Nephrol Dial. 2018 Jan 19;8(1):10-19. doi: 10.1159/000486158. eCollection 2018 Jan-Apr. Case Rep Nephrol Dial. 2018. PMID: 29594146 Free PMC article.

5

HLA in transplantation.

Montgomery RA, Tatapudi VS, Leffell MS, Zachary AA. Montgomery RA, et al. Nat Rev Nephrol. 2018 Sep;14(9):558-570. doi: 10.1038/s41581-018-0039-x. Nat Rev Nephrol. 2018. PMID: 29985463 Review.

6

IdeS (Imlifidase): A Novel Agent That Cleaves Human IgG and Permits Successful Kidney Transplantation Across High-strength Donor-specific Antibody.

Lonze BE, Tatapudi VS, Weldon EP, Min ES, Ali NM, Deterville CL, Gelb BE, Benstein JA, Dagher NN, Wu M, Montgomery RA. Lonze BE, et al. Ann Surg. 2018 Sep;268(3):488-496. doi: 10.1097/SLA.0000000000002924. Ann Surg. 2018. PMID: 30004918 Clinical Trial.

7

Therapeutic Modulation of the Complement System in Kidney Transplantation: Clinical Indications and Emerging Drug Leads.

Tatapudi VS, Montgomery RA. Tatapudi VS, et al. Front Immunol. 2019 Oct 1;10:2306. doi: 10.3389/fimmu.2019.02306. eCollection 2019. Front Immunol. 2019. PMID: 31632397 Free PMC article. Review.

8

Successful A2 to B Deceased Donor Kidney Transplant after Desensitization for High-Strength Non-HLA Antibody Made Possible by Utilizing a Hepatitis C Positive Donor.

Karpel HC, Ali NM, Lawson N, Tatapudi VS, Friedlander R, Philogene MC, Montgomery RA, Lonze BE. Karpel HC, et al. Case Rep Transplant. 2020 Mar 13;2020:3591274. doi: 10.1155/2020/3591274. eCollection 2020. Case Rep Transplant. 2020. PMID: 32231847 Free PMC article.

9

Impact of the 2014 kidney allocation system changes on trends in A2/A2B into B kidney transplantation and organ procurement organization reporting of donor subtyping.

Stern J, Alnazari N, Tatapudi VS, Ali NM, Stewart ZA, Montgomery RA, Lonze BE. Stern J, et al. Among authors: tatapudi vs. Clin Transplant. 2021 Sep;35(9):e14393. doi: 10.1111/ctr.14393. Epub 2021 Jun 29. Clin Transplant. 2021. PMID: 34165821

10

Results of Two Cases of Pig-to-Human Kidney Xenotransplantation.

Montgomery RA, Stern JM, Lonze BE, Tatapudi VS, Mangiola M, Wu M, Weldon E, Lawson N, Deterville C, Dieter RA, Sullivan B, Boulton G, Parent B, Piper G, Sommer P, Cawthon S, Duggan E, Ayares D, Dandro A, Fazio-Kroll A, Kokkinaki M, Burdorf L, Lorber M, Boeke JD, Pass H, Keating B, Griesemer A, Ali NM, Mehta SA, Stewart ZA. Montgomery RA, et al. Among authors: tatapudi vs. N Engl J Med. 2022 May 19;386(20):1889-1898. doi: 10.1056/NEJMoa2120238. N Engl J Med. 2022. PMID: 35584156

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page